OptimizeRx Corporation (OPRX): Price and Financial Metrics
GET POWR RATINGS... FREE!
OPRX POWR Grades
- OPRX scores best on the Growth dimension, with a Growth rank ahead of 86.3% of US stocks.
- The strongest trend for OPRX is in Momentum, which has been heading down over the past 31 weeks.
- OPRX's current lowest rank is in the Value metric (where it is better than 5.79% of US stocks).
OPRX Stock Summary
- OPRX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,565.33 -- higher than 97.22% of US-listed equities with positive expected earnings growth.
- For OPRX, its debt to operating expenses ratio is greater than that reported by just 4.75% of US equities we're observing.
- As for revenue growth, note that OPRX's revenue has grown 74.09% over the past 12 months; that beats the revenue growth of 92.33% of US companies in our set.
- Stocks that are quantitatively similar to OPRX, based on their financial statements, market capitalization, and price volatility, are VERU, CDMO, DSS, SITC, and NVGS.
- Visit OPRX's SEC page to see the company's official filings. To visit the company's web site, go to www.optimizerx.com.
OPRX Price Target
For more insight on analysts targets of OPRX, see our OPRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $74.00 | Average Broker Recommendation | 1.4 (Strong Buy) |
OPRX Stock Price Chart Interactive Chart >
OPRX Price/Volume Stats
| Current price | $52.06 | 52-week high | $63.98 |
| Prev. close | $53.65 | 52-week low | $12.38 |
| Day low | $52.00 | Volume | 195,300 |
| Day high | $54.30 | Avg. volume | 237,960 |
| 50-day MA | $49.63 | Dividend yield | N/A |
| 200-day MA | $38.17 | Market Cap | 899.60M |
OptimizeRx Corporation (OPRX) Company Bio
OptimizeRx Corporation operates an Internet website through which it offers advice to consumers on how to save money on branded prescription and over-the-counter healthcare products.
Latest OPRX News From Around the Web
Below are the latest news stories about OptimizeRx Corp that investors may wish to consider to help them evaluate OPRX as an investment opportunity.
OptimizeRx Aligned With Pharma Across Fast Growing Specialty Therapeutic AreasContinued focus on building and closing pipeline of enterprise solutions across oncology, cardiology and immunologyROCHESTER, Mich., June 15, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, discusses aspects of the Company’s 2021 strategic operating plan which has been aligned with the pharma industry’s market sizing opportunity across fast growing specialty therapeutic a |
OptimizeRx Named to LD Micro’s “Hall of Fame” As One of the Top 50 Performing CompaniesROCHESTER, Mich., June 01, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo, OptimizeRx’s CEO, will participate in the LD Micro Virtual Invitational (XI) conference on June 8, 2021. OptimizeRx will be inducted into LD Micro’s “Hall of Fame”, ranked number 36 of 50. The LD Micro Hall of Fame list highlights the top 50 best performing companies out of over 2,000 companies which have attended prior LD Micro conferences. The live webcast and replay of the presentation will be made available on the day of the event at investors.optimizerx.com/events-and-presentations. Conference details (LD Micro Virtual Invitational (XI))Date:Tuesday, J... |
OptimizeRx to Participate in the William Blair 41st Annual Growth Stock ConferenceROCHESTER, Mich., May 25, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo, OptimizeRx’s, CEO will participate in a fireside chat at the William Blair 41st Annual Growth Stock Conference. The live webcast and replay of the presentation will be made available on the day of the event at investors.optimizerx.com/events-and-presentations. Conference Details: William Blair' s 41st Annual Growth Stock ConferenceLocation: Virtual 2Date:Wednesday, June 2Time: 9:20-9:50 AM CT / 10:20-10:50 AM ET About OptimizeRxOptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. C... |
OptimizeRx Corp. (OPRX) Q1 Earnings and Revenues Beat EstimatesOptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 200.00% and 8.79%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock? |
OptimizeRx Reports First Quarter 2021 Financial Results, Revenue Up 48% on Rising Enterprise Adoption of Digital HealthRevenue Up 48% to $11.2 million, closing on 33 enterprise contractsExpanded recurring revenue stream, reaching new base of customersCash flow positive from operations of $1.7 million ROCHESTER, Mich., May 06, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported results for the three months ended March 31, 2021. Quarterly comparisons are to the same year-ago period. Financial Highlights Revenue in the first quarter of 2021 increased 48% to a record $11.2 million, from $7.6 million as compared to the same year ago period.Gross profit in the first quarter of 2021 increased 41% to $6.1 million.GAAP net loss totaled $0.6 million or $(0.04) per basic and diluted sh... |
OPRX Price Returns
| 1-mo | 6.53% |
| 3-mo | -4.07% |
| 6-mo | 57.28% |
| 1-year | 300.15% |
| 3-year | 402.03% |
| 5-year | 4,720.37% |
| YTD | 67.07% |
| 2020 | 203.41% |
| 2019 | -6.38% |
| 2018 | 598.73% |
| 2017 | 93.83% |
| 2016 | -33.61% |
Continue Researching OPRX
Here are a few links from around the web to help you further your research on OptimizeRx Corp's stock as an investment opportunity:OptimizeRx Corp (OPRX) Stock Price | Nasdaq
OptimizeRx Corp (OPRX) Stock Quote, History and News - Yahoo Finance
OptimizeRx Corp (OPRX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...